Virax Biolabs Group annual gross profit
2021
2023
2024
2025
2026
Virax Biolabs Group Gross Profit Growth & History (VRAX)
Virax Biolabs Group's gross profit was $7,690 for fiscal 2026.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $7,690 | $60,757 | — |
| 2025 | 2025-03-31 | −$53,067 | −$103,657 | — |
| 2024 | 2024-03-31 | $50,590 | $51,955 | — |
| 2023 | 2023-03-31 | −$1,365 | — | — |
| 2021 | 2021-03-31 | −$9,434 | — | — |
Virax Biolabs Group gross profit trends
Over the last five fiscal years, Virax Biolabs Group's gross profit increased from −$9,434 to $7,690, a change of $17,124.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group source filings ↗